Trials / Completed
CompletedNCT01499381
EMBRACE1: Prostate Biorepository
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,290 (actual)
- Sponsor
- Caris Science, Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of prostate cancer in men that have been scheduled for a prostate biopsy. Primarily, results of the Carisome Prostate assay will be compared with pathology results of prostate biopsy procedures. Secondarily, the performance of the Carisome Prostate test will be compared to the current standard of care for the detection of prostate cancer.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-12-26
- Last updated
- 2016-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01499381. Inclusion in this directory is not an endorsement.